Analysis of combined genotypes of uncoupling protein 2, peroxisome proliferator-activated receptor γ and β3-adrenergic receptor, in type 2 diabetes in Korean

被引：0
|
作者：
Moon, MK
Cho, YM
Jung, HS
Lee, YY
Kin, JH
Park, YJ
Park, JY
Lee, KU
Park, KS
Kim, SY
Lee, HK
Shin, HD
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A514 / A514
页数：1
相关论文
共 50 条
  • [21] Design, synthesis and evaluation of peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes
    Das, Saibal Kumar
    Abbineni, Chandrasekhar
    Rao, Krovvidi Venkata Lakshmi Narasimha
    Iqbal, Javed
    Babu, Ravi Krishna
    Chakrabarti, Ranjan
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (01) : 27 - 32
  • [22] Genetic Variation in the Peroxisome Proliferator-Activated Receptor (PPAR) and Peroxisome Proliferator-Activated Receptor Gamma Co-activator 1 (PGC1) Gene Families and Type 2 Diabetes
    Villegas, Raquel
    Williams, Scott M.
    Gao, Yu-Tang
    Long, Jirong
    Shi, Jiajun
    Cai, Hui
    Li, Honglan
    Chen, Ching-Chu
    Tai, E. Shyong
    Hu, Frank
    Cai, Qiuyin
    Zheng, Wei
    Shu, Xiao-Ou
    ANNALS OF HUMAN GENETICS, 2014, 78 (01) : 23 - 32
  • [23] Uncoupling Protein 2 and Peroxisome Proliferator-Activated Receptor γ Gene Polymorphisms in Association with Diabetes Susceptibility in Chinese Han Population with Variant Glucose Tolerance
    Zhou, Meicen
    He, Shuli
    Ping, Fan
    Li, Wei
    Zhu, Lixin
    Cui, Xiangli
    Feng, Linbo
    Zhao, Xuefeng
    Zhang, Huabing
    Li, Yuxiu
    Sun, Qi
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [24] Eigenvalue analysis of peroxisome proliferator-activated receptor γ agonists
    Liao, CZ
    Xie, AH
    Shi, LM
    Zhou, JJ
    Lu, XP
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (01): : 230 - 238
  • [25] Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Mancini, FP
    Vaccaro, O
    Sabatino, L
    Tufano, A
    Rivellese, AA
    Riccardi, G
    Colantuoni, V
    DIABETES, 1999, 48 (07) : 1466 - 1468
  • [26] Heterogeneous effect of peroxisome proliferator-activated receptor γ2 Ala12 variant on type 2 diabetes risk
    Ludovico, Ornella
    Pellegrini, Fabio
    Di Paola, Rosa
    Minenna, Antonio
    Mastroianno, Sandra
    Cardellini, Marina
    Marini, Maria Adelaide
    Andreozzi, Francesco
    Vaccaro, Olga
    Sesti, Giorgio
    Trischitta, Vincenzo
    OBESITY, 2007, 15 (05) : 1076 - 1081
  • [27] The peroxisome proliferator-activated receptor-γ2 P12A polymorphism and type 2 diabetes in an Arab population
    Wakil, SM
    Al-Rubeaan, K
    Alsmadi, O
    Imtiaz, F
    Carroll, P
    Rajab, M
    Al-Katari, S
    Al-Katari, M
    Meyer, BF
    DIABETES CARE, 2006, 29 (01) : 171 - 172
  • [28] Therapeutic significance of peroxisome proliferator-activated receptor modulators in diabetes
    Ram, VJ
    DRUGS OF TODAY, 2003, 39 (08) : 609 - 632
  • [29] Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes and beyond
    Jones, AB
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 540 - 552
  • [30] Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes
    Abdallah, Hossam M.
    El Dine, Riham Salah
    Mohamed, Gamal A.
    Ibrahim, Sabrin R. M.
    Shehata, Ibrahim A.
    El-Halawany, Ali M.
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 : 28 - 44
12345